Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Compare which has lower fees between index funds and target date retirement options to understand true costs and impact on returns. Make smarter retirement choices with clear, practical guidance.
28,375 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Delve into the investing philosophy of Bill Miller IV, the CIO and PM behind Miller Value Fund. Learn how high-convic...
A massive new funding request for Iran-related operations has financial markets and households weighing the longer-te...
A resurfaced teen photo sparked online backlash for Hudson Williams, highlighting how reputational events can ripple ...
UBS lifts industries $140 price target on CF Industries as nitrogen markets tighten amid supply disruptions. The move...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
This original millionaire interview-style guide dives into the daily habits, smart choices, and concrete steps that h...
Two ETFs that use option strategies are paying monthly distributions that exceed traditional dividend bets, signaling...
Two 2x NVIDIA ETFs, NVDX and NVDL, aim to mirror double daily moves in NVIDIA. This report breaks down how daily comp...
SpaceX is preparing the largest IPO in history, valued near $1.77 trillion, as Wall Street debates whether AI-driven ...